Investor profile
Family Offices has backed 40 European tech companies across 41 funding rounds between 2017 and 2026, joining rounds totalling €346M. Most active in Healthtech and Fintech. Data as of 22 Sept 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Schuttflix | Germany | 1 | €45M |
| Protembis | Germany | 1 | €30M |
| Tissium | France | 1 | €30M |
| Arctic Therapeutics | Iceland | 1 | €27M |
| Syntetica | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Schuttflix | Other | €45M | 2023-08 |
| Tissium | Other | €30M | 2026-06 |
| Protembis | Series B | €30M | 2024-03 |
| Arctic Therapeutics |
| 1 |
| €26M |
| Hexa | UK | 1 | €20M |
| Eir Insurance | Sweden | 1 | €20M |
| Fernride | Germany | 1 | €18M |
| Qomodo | Italy | 1 | €14M |
| Capalo AI | Finland | 1 | €11M |
| Strong by Form | Spain | 2 | €11M |
| deltaVision | Germany | 1 | €10M |
| EVerZom | France | 1 | €10M |
| Yeastup | Belgium | 1 | €9.5M |
| WoW | Spain | 1 | €8.0M |
| Syroco | France | 1 | €7.5M |
| Transferz | Netherlands | 1 | €6.5M |
| Noriware | Germany | 1 | €4.3M |
| Nuuron | Germany | 1 | €3.5M |
| Loxa | UK | 1 | €3.1M |
| Brickwise | Austria | 1 | €3.1M |
| Kumulus Water | France | 1 | €3.1M |
| Scanvio | Switzerland | 1 | €2.9M |
| Meletios Therapeutics | France | 1 | €2.8M |
| Zazume | Spain | 1 | €2.5M |
| Health Lean Analytics (HLA) | Spain | 1 | €2.1M |
| Volders | Germany | 1 | €2.0M |
| Iusful | Italy | 1 | €2.0M |
| Captoplastic | Spain | 1 | €2.0M |
| Blue Longevity Clinic | Bulgaria | 1 | €2.0M |
| €27M |
| 2025-01 |
| Hexa | Other | €20M | 2023-11 |
| Eir Insurance | Growth/Late | €20M | 2025-10 |
| Fernride | Series A | €18M | 2025-09 |
| Qomodo | Series A | €14M | 2025-01 |
| Capalo AI | Series A | €11M | 2026-02 |
| EVerZom | Other | €10M | 2025-10 |
